Integrated NGS Workflow from Sample Collection to Insight Generation

DNA sequencing technologies have evolved over time into next-generation sequencing (NGS), which has overcome traditional sequencing limitations, and enables the simultaneous screening of multiple genes in multiple samples. NGS can be used to detect numerous genetic variants such as single nucleotide variants (SNVs), multiple nucleotide variants (MNVs), insertions and deletions (Indels) and copy number variants (CNVs).

Abnova provides two gene panels for NGS, Actionable Insights Tumor Panel V2 and Actionable Insights Tumor Panel V3, validated for use with samples from FFPE tissues, circulating tumor DNA (ctDNA) and circulating tumor cells (CTCs). These two solutions utilize target enrichment technology to sequence specific regions of interest in the human genome and enrich the most relevant genes and variants, aiming to deliver critical insights for cancer clinical research.

Abnova NGS Workflow


GeneReader System

Streamlining the workflow from sample collection to insight generation, our NGS solutions powered by GeneReader System, help cancer research labs to sequence, analyze and interpret actionable targets with confidence and efficiency.


  • Multiplexing
  • Specific enrichment
  • High sensitivity
  • Reduced hands-on time
  • Actionable insights
  • Integrated bioinformatic pipeline

Applications in Geneteic Research: NGS vs. Sanger Sequencing

  Next-Generation Sequencing Sanger Sequencing
Single Site Yes Yes
 Single Gene Yes Yes
Multiple Genes Yes No
Exome Yes No
Whole Genome Yes No
De Novo Genome Yes No
Transcriptome Yes No

Abnova NGS-related Services

For any inquiry, please contact : OEM@abnova.com

For any inquiry, please contact
We have placed cookies on your device to make our website better. If you continue using our website, we assume you agree to it. You can learn more details here .